additional navigation


You are here:

Corporate Profile Folder

Download Corporate Profile Folder (.pdf, 3.6 MB)

AOP Orphan Polska

The country organization in Poland was established in 2002 with a particular focus on the therapeutic areas of Hematology and Cardiology & Pulmonology. With the approval of AOP Orphan’s leaingd product Thromboreductin in 2003 and Remodulin in 2006, the organization was enlarged with the addition of a strong science-orientated marketing and sales team.


AOP Orphan Pharmaceuticals Poland Sp. z o.o.
Al. Niepodległości 69
02-626 Warszawa
Tel +48 22 322 76 80
Fax +48 22 322 76 81

AOP Orphan Contact

AOP Orphan Poland

AOP Orphan worldwide

Products & Area of treatment